Trevi Therapeutics
TRVI
TRVI
16 hedge funds and large institutions have $88M invested in Trevi Therapeutics in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.87M | |
| 2 | +$740K | |
| 3 | +$263K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$165K |
| 5 |
BlackRock
New York
|
+$95.7K |
Top Sellers
| 1 | -$9.87M | |
| 2 | -$1.93M | |
| 3 | -$386K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$194K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$75.8K |